Xiaobao Dong et al. developed a network-based framework to measure cancer diversity for cancer driver mutations, finding that half of driver genes contain both cancer type-specific and pancancer mutations. They show that the specificity of mutations could influence therapeutic responses.
- Xiaobao Dong
- Dandan Huang
- Mulin Jun Li
